CBS2023
The 15th CBS event, CBS 2023, will feature specialized academic forums covering a wide range of topics, including Complex Coronary Intervention, Intravascular Imaging, Pulmonary Arterial Hypertension, Structural Heart Disease Intervention, Arrhythmia, Heart Failure, Hypertension, Basic Research, and Clinical Trial. The conference aims to showcase advanced medical technologies and treatment methods in the field of cardiovascular intervention, along with in-depth discussions on cutting-edge trends. It will also provide a platform for open dialogues among top experts, creating a professional, in-depth, and exciting academic experience for all participants.
Results:
Date/Time
Room
Session
Name
Role
Presentation Title
9:40 am-11:45 am,
Friday, December 1, 2023
Friendship Hall, 2nd Floor, Zijin Building Session 1 Update Issues for Group I PAH
Cheng Wang Discussant
9:40 am-9:45 am,
Friday, December 1, 2023
Friendship Hall, 2nd Floor, Zijin Building Session 1 Update Issues for Group I PAH
Shao-Liang Chen Host Welcome Introduction
9:45 am-10:00 am,
Friday, December 1, 2023
Friendship Hall, 2nd Floor, Zijin Building Session 1 Update Issues for Group I PAH
Raymond L. Benza Speaker Classifications of PAH
10:05 am-10:20 am,
Friday, December 1, 2023
Friendship Hall, 2nd Floor, Zijin Building Session 1 Update Issues for Group I PAH
Zhicheng Jing Speaker Genetics and Genomics in PAH
10:25 am-10:40 am,
Friday, December 1, 2023
Friendship Hall, 2nd Floor, Zijin Building Session 1 Update Issues for Group I PAH
Jiang Li Speaker Etiology & Pathological Mechanism of PAH
10:45 am-11:00 am,
Friday, December 1, 2023
Friendship Hall, 2nd Floor, Zijin Building Session 1 Update Issues for Group I PAH
Lihua Guan Speaker Diagnosis of PAH & Possible Outlook
11:05 am-11:20 am,
Friday, December 1, 2023
Friendship Hall, 2nd Floor, Zijin Building Session 1 Update Issues for Group I PAH
Qiguang Wang Speaker Classification and Interventional Timing of Congenital Heart Disease Comorbid PAH
11:25 am-11:40 am,
Friday, December 1, 2023
Friendship Hall, 2nd Floor, Zijin Building Session 1 Update Issues for Group I PAH
Changming Xiong Speaker Treatment of PAH
9:45 am-11:30 am,
Friday, December 1, 2023
Tulip Hall,, 2nd Floor, Zijin Building Clinical trial forum Ⅰ
Yi Li Moderator
9:45 am-11:30 am,
Friday, December 1, 2023
Tulip Hall,, 2nd Floor, Zijin Building Clinical trial forum Ⅰ
Tao Ye Moderator
9:45 am-11:30 am,
Friday, December 1, 2023
Tulip Hall,, 2nd Floor, Zijin Building Clinical trial forum Ⅰ
Yan Yan Discussant
9:45 am-11:30 am,
Friday, December 1, 2023
Tulip Hall,, 2nd Floor, Zijin Building Clinical trial forum Ⅰ
Chunli Shao Discussant
9:45 am-11:30 am,
Friday, December 1, 2023
Tulip Hall,, 2nd Floor, Zijin Building Clinical trial forum Ⅰ
Fentang Gao Discussant
9:45 am-10:10 am,
Friday, December 1, 2023
Tulip Hall,, 2nd Floor, Zijin Building Clinical trial forum Ⅰ
Yi Li Speaker OPT-BIRISK trial: interpretation of extended antiplatelet therapy with clopidogrel alone versus dual antiplatelet therapy (DAPT) in high-risk patients
10:20 am-10:45 am,
Friday, December 1, 2023
Tulip Hall,, 2nd Floor, Zijin Building Clinical trial forum Ⅰ
Hang Zhang Speaker Interpretation of the 3-year clinical results of PADN-5 Trial
10:55 am-11:20 am,
Friday, December 1, 2023
Tulip Hall,, 2nd Floor, Zijin Building Clinical trial forum Ⅰ
Zhen Ge Speaker Interpretation of T-PASS trial
9:50 am-11:30 am,
Friday, December 1, 2023
Peace Hall, 2nd Floor, Zijin Building Optimal Strategy for Left Main Disease in 2023
Xiangqi Wu Translator
9:50 am-11:30 am,
Friday, December 1, 2023
Peace Hall, 2nd Floor, Zijin Building Optimal Strategy for Left Main Disease in 2023
Gregg W. Stone Moderator
9:50 am-11:30 am,
Friday, December 1, 2023
Peace Hall, 2nd Floor, Zijin Building Optimal Strategy for Left Main Disease in 2023
Gary S. Mintz Moderator
9:50 am-11:30 am,
Friday, December 1, 2023
Peace Hall, 2nd Floor, Zijin Building Optimal Strategy for Left Main Disease in 2023
Spencer B. King III Moderator
Records:819 Pre[2] [3] [4] [5] [6] [7] [8] [9] [10] [11] Next

http://www.cbsmd.cn Contact us by cbs@cbsmd.cn

Copyright ⓒ CBSMD Nanjing China. All rights reserved.